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Abstract
Cellular electrophysiology experiments, important for understanding cardiac arrhythmia mechanisms, are usually performed
with channels expressed in non myocytes, or with non-human myocytes. Differences between cell types and species affect
results. Thus, an accurate model for the undiseased human ventricular action potential (AP) which reproduces a broad range
of physiological behaviors is needed. Such a model requires extensive experimental data, but essential elements have been
unavailable. Here, we develop a human ventricular AP model using new undiseased human ventricular data: Ca
2+ versus
voltage dependent inactivation of L-type Ca
2+ current (ICaL); kinetics for the transient outward, rapid delayed rectifier (IKr),
Na
+/Ca
2+ exchange (INaCa), and inward rectifier currents; AP recordings at all physiological cycle lengths; and rate
dependence and restitution of AP duration (APD) with and without a variety of specific channel blockers. Simulated APs
reproduced the experimental AP morphology, APD rate dependence, and restitution. Using undiseased human mRNA and
protein data, models for different transmural cell types were developed. Experiments for rate dependence of Ca
2+ (including
peak and decay) and intracellular sodium ([Na
+]i) in undiseased human myocytes were quantitatively reproduced by the
model. Early afterdepolarizations were induced by IKr block during slow pacing, and AP and Ca
2+ alternans appeared at rates
.200 bpm, as observed in the nonfailing human ventricle. Ca
2+/calmodulin-dependent protein kinase II (CaMK) modulated
rate dependence of Ca
2+ cycling. INaCa linked Ca
2+ alternation to AP alternans. CaMK suppression or SERCA upregulation
eliminated alternans. Steady state APD rate dependence was caused primarily by changes in [Na
+]i, via its modulation of the
electrogenic Na
+/K
+ ATPase current. At fast pacing rates, late Na
+ current and ICaL were also contributors. APD shortening
during restitution was primarily dependent on reduced late Na
+ and ICaL currents due to inactivation at short diastolic
intervals, with additional contribution from elevated IKr due to incomplete deactivation.
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Introduction
The first step toward preventing sudden cardiac death is under-
standing the basic mechanisms of ventricular arrhythmias at the
level of ion channel currents and the single myocyte action potential
(AP), using both experiments[1] and theoretical models[2].
Obtaining ventricular myocytes from human hearts for the study
of arrhythmia mechanisms is both rare and technically challenging.
Consequently, these mechanisms are usually studied with human
channels expressed in non myocytes, or with non human (rodent or
other mammalian) myocytes. However, these approaches have
limitations, because functionally important accessory subunits and
anchoring proteins native to ventricular myocytes[3] are absent in
expression systems, and even among mammalian ventricular
myocytes, ion channel kinetics[4,5,6] and consequently arrhythmia
mechanisms are strongly species dependent.
These issues limit the applicability of results from animal studies
to human cardiac electrophysiology and clinical arrhythmia[7].
Measurements from undiseased human ventricular myocytes are a
requisite for understanding human cell electrophysiology. Here,
we present data from over 100 undiseased human hearts for steady
state rate dependence, and restitution of the ventricular AP.
Importantly, we also obtained essential new measurements for
the L-type Ca
2+ current, K
+ currents, and Na
+/Ca
2+ exchange
current from undiseased human ventricle. These previously
unavailable data are critically important for correct formulation
of mathematical models for simulation of electrophysiology and
cellular arrhythmia mechanisms[8]. Using the new data together
with previously published experiments, a detailed mathematical
model of undiseased human ventricular myocyte electrophysiology
and Ca
2+ cycling was developed and thoroughly validated over the
entire range of physiological frequencies. This model is referred to
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Model comparisons are conducted with the ten Tusscher-Panfilov
(TP) model[9], and the Grandi-Bers (GB) model[10].
The ORd model was used to describe cellular electrophysiology
mechanisms specific to human ventricular myocytes. Underlying
mechanisms of AP duration (APD) rate dependence and APD
restitution were investigated. The effects of Ca
2+/calmodulin-
dependent protein kinase II (CaMK) on known ionic current and
Ca
2+ cycling targets were incorporated and studied. Early
afterdepolarizations (EADs) and alternans were reproduced by
the model. These are important arrhythmogenic phenomena that
must be reproduced in order to study the mechanisms of cardiac
arrhythmias in human and simulate clinical interventions such as
drugs.
Results
Throughout, new undiseased human ventricle experimental
data are represented by white circles or white squares for isolated
myocyte or small tissue preparation measurements, respectively.
Previously published nonfailing human ventricle experimental
data are shown with black symbols. Other data classification
schemes are provided case by case in figure legends.
Formulation, Validation and Properties of Simulated
Currents: L-type Ca
2+ Current (ICaL)
Data for ICaL in the undiseased human ventricle are from
Magyar et al.[11] and Fulop et al.[12] (both at 37uC, model
validation in Figure 1C). Magyar et al. measured steady state
activation, steady state inactivation, and the current voltage (I–V)
curve. Fulop et al. measured recovery from inactivation. However,
neither study separated Ca
2+ dependent inactivation (CDI) from
voltage dependent inactivation (VDI). In fact, no published data
are available which separate CDI and VDI in the undiseased or
nonfailing human ventricle. For this measurement, we made new
recordings in undiseased human ventricular myocytes at 37uC
(Figure 1, current traces and white circles).
Measurements were carried out with Ca
2+ as charge carrier,
allowing both CDI and VDI, or with Ba
2+ as charge carrier,
allowing only VDI. Results for Sr
2+ were similar to those for Ba
2+.
From holding potential of 260 mV, 75 ms steps were to potentials
ranging from 240 to +50 mV (10 mV increments, 3 second
interpulse interval, Figure 1A). 75 ms was sufficient for compar-
ison of CDI and VDI, since it is in the early phase of decay in
which CDI effects are most prominent[13]. Simulated current
traces for CDI+VDI and for VDI–alone were similar to the
experiments.
Fractional remaining current (FRC, at time t and voltage Vm,
FRC(t,Vm)=I(t,Vm)/Ipeak(Vm)) quantified the voltage and time
dependence of inactivation for comparison between charge
carriers. Figure 1B compares FRC for Ba
2+ (experiments top left,
simulations right), and Ca
2+ (experiments bottom left, simulations
right). With Ba
2+ as the charge carrier, FRC monotonically
decreased with increasing voltage at all times after peak current.
This finding is consistent with dependence of inactivation on
voltage alone. In contrast, for Ca
2+ currents, FRC did not decrease
monotonically with increasing voltage. Rather, Ca
2+ current FRC
curves appear to be effectively voltage independent. FRC for
CDI+VDI was statistically different from FRC for VDI-alone at
the more hyperpolarized potentials (220 to 0 mV, unpaired two-
tailed t-test, p,0.01). Ca
2+ ions caused additional inactivation at
these voltages, where VDI-alone was relatively weak. Since the
only difference between Ca
2+ and Ba
2+ cases was the charge
carrier, it follows that Ca
2+ ions themselves were the source of the
additional inactivation. This is evidence that currents carried by
Ba
2+ inactivate due to VDI only, while Ca
2+ currents inactivate
due to both VDI and CDI[14]. There is evidence that Ba
2+ can
cause ion dependent inactivation[15]. However, Ba
2+-dependent
inactivation was estimated to be 100-fold weaker than CDI[16],
and its effects were not appreciable in FRC experiments.
To modulate VDI versus CDI in the model, the n gate was
introduced, the value of which represents the fraction of channels
operating in CDI mode. Under physiological conditions, ICaL
inactivation is caused by a combination of both CDI and VDI.
That is, n is between 0 (all VDI) and 1 (all CDI). This model was
based on experiments by Kim et al.[17], where CDI was observed
to function as a faster VDI, activated by elevated Ca
2+. Thus, both
CDI and VDI are voltage dependent. The rate of decay in CDI
mode is faster than that in VDI mode. The Mahajan et al.[18] and
Decker et al.[19] ICaL models work similarly.
The n gate is diagrammed in Figure 1E. Rates k1 and k-1
represent binding/unbinding of Ca
2+ to channel bound calmodulin
(CaM)[20]. There are four identical binding sites. Rates k2 and k-2
represent activation/deactivation of CDI mode (black circle,
asterisk), which occurs when all Ca
2+ binding sites are occupied.
We considered that the four Ca
2+ binding transitions are in rapid
equilibrium and solved the reversible two state reaction of Ca
2+/
CaM binding and CDI mode activation to obtain the differential
equation describing the n gate (Supplement Text S1, page 10).
In both CDI and VDI modes, there are two weighted time
constants for inactivation (time constant weighting described in
Methods). We determined time constants for CDI and n gate
kinetics in an attempt to represent the shape and magnitude of the
FRC measurements (i.e. CDI reduced FRC, particularly at
negative potentials). Time constants for VDI gates were deter-
mined by inactivation of Ba
2+ currents (Figure 1C). AP clamp
simulations using the formulated ICaL model were similar to AP
clamp experiments, where ICaL was defined as the 1 mM
nisoldipine sensitive current (Figure 1D). Specifically, currents
showed spike and dome morphology. In experiments, peak current
was 23.0 mA/mF. It was 22.7 mA/mF in simulations. Fast
inactivation was 2.5 fold faster when phosphorylated by CaMK,
similar to the Decker et al. dog ICaL model[19] and as measured
experimentally[21].
Author Summary
Understanding and preventing irregular heart rhythms
that can lead to sudden death begins with basic research
regarding single cell electrical behavior. Most of these
studies are performed using non-human cells. However,
differences between human and non-human cell proper-
ties affect experimental results and invoke different
mechanisms of responses to heart rate changes and to
drugs. Using essential and previously unavailable experi-
mental data from human hearts, we developed and
validated an accurate mathematical model of the human
cardiac cell. We compared cellular behaviors and mecha-
nisms to an extensive dataset including measurements
from more than 100 undiseased human hearts. The model
responds to pacing rate and premature beats as in
experiments. At very fast pacing rates, beat to beat
alternations in intracellular calcium concentration and
electrophysiological behavior were observed as in human
heart experiments. In presence of drug block, arrhythmic
behavior was observed. The basis for these and other
important rhythmic and irregular rhythm behaviors was
investigated using the model.
Undiseased Human Cardiac Action Potential
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+ Current (Ito)
The model for Ito was formulated based on newly measured
experimental data. The measurements were from isolated
undiseased human ventricular myocytes at 37uC (Figure 2A, white
circles), and were carried out with the addition of 1 mM nisoldipine
to the standard bath solution (see Methods) to block ICaL. The
holding potential was 290 mV. Currents were activated by a
300 ms step to various potentials. Inactivation time constants were
determined from exponential fits to decay of these traces. To
measure steady state inactivation, 500 ms steps from 290 mV to
various potentials were followed by test pulses to 50 mV. Recovery
from inactivation was determined at 290 mV, using P1/P2 pulses
of 200 ms to 50 mV at varying interpulse intervals in a double
pulse protocol.
The time constant for activation was determined by fitting time
to peak from a digitized current trace (Amos et al.[22], their
Figure 12C, in undiseased human ventricle at 37uC; ta=2.645 ms
at Vm=+40 mV). Greenstein et al.[23] showed time to peak for
hKv4.3 expressed in mouse fibroblast cells. The model provides a
qualitative match to these data (considering temperature and
expression system differences). That is, the model activation time
constant decreases from a peak value of 6.5 to 1.5 ms in near
linear fashion with increasing voltage from 220 to 60 mV.
The inactivation gate has two time constants, each with voltage
dependent weighting. Inactivation kinetics and the I–V curve are
accurate to the experimental data. A small divergence between
simulations and experiments was observed at hyperpolarized
potentials along the I–V curve (simulated current was less than in
experiments). This may be due to the fact that experimentally
measured currents were small and difficult to measure at these
potentials. In fact, current was not measureable in 21, 11, 5, and 1
out of 23 cells at Vm=240, 230, 220, and 210 mV,
respectively. Currents with zero values were not included in the
experimental I–V averages. However, these currents were
included in averages for obtaining steady state activation and
steady state inactivation curves in the model. This prevented over
representation of the window current (small, appearing late during
phase-3 of the AP, shown later). The conductance of the Ito model
was set so that phase-1 behavior of the simulated AP would be
similar to undiseased human endocardium experiments (small in
endocardium; maximum value ,1 mA/mF). Measured endocar-
dial APs showed rapid phase-1 repolarization, but did not show
positive time derivatives during phase-1 (true notching was
generally not observed). Thus, model Ito conductance was set to
the maximum level which did not violate these observations
(,1 mA/mF peak current at 1 Hz pacing).
CaMK effects on Ito were incorporated based on measurements
by Tessier et al.[24] and Wagner et al.[25]. As in Tessier et al.,
CaMK shifted the voltage dependence of steady state activation
10 mV in the depolarization direction, and the time constant for
development of inactivation was increased (multiplicative factor fit
to match the voltage dependent increase). Wagner et al. showed
that the time constant for recovery from inactivation was affected
by CaMK (,2 fold faster).
Na
+/Ca
2+ Exchange Current (INaCa)
The INaCa model was formulated using measurements from
undiseased human ventricular myocytes at 37uC (Figure 2B, white
circles). The model was based on the framework established by
Kang and Hilgemann[26], which allows for unlikely occurrence of
inward Na
+ leak, without Ca
2+ exchange. The Hilgemann model
shows Na
+:Ca
2+ exchange stoichiometry slightly greater than 3.0,
as has been observed by others[27,28]. Though the Hilgemann
model is mechanistically novel in this way, it can still reproduce all
Na
+,C a
2+ and voltage dependent properties observed by Weber
et al.[29] in the nonfailing human ventricle. Compare Hilgemann
and Weber data to our simulated reproductions in Supplement
Figures S1, S2 and S3 in Text S1. As in the Faber-Rudy[30] and
Hund-Decker-Rudy models[19,31], we included 20% of the
exchanger in the Ca
2+ diffusion subspace[32,33]. The choice to
include 20% in the subspace in human is validated based on its
effect on the rate dependence of peak [Ca
2+]i (results in
Supplement Figure S17 in Text S1). Values above or below
20% disrupt the demonstrated correspondence of peak [Ca
2+]i
rate dependence with experiments (see section on Na
+ and Ca
2+
rate dependence).
Inward Rectifier K
+ Current (IK1)
The model for IK1 was constructed based primarily on new
experimental data, measured at 37uC in undiseased isolated
human ventricular myocytes as the 0.5 mM BaCl2 sensitive
current (Figure 2C, white circles). Current was elicited with steps
from 290 mV to various potentials for 300 ms. The current that
remained at the end of the steps was recorded as IK1.
Two gates were used in the model: RK1, the instantaneous
rectification gate, and xK1, the time dependent inactivation gate.
Importantly, previous models[9,10,34,35] have ignored both
inactivation gating, and detailed [K
+]o-dependence of IK1
(exception, IK1 equations by Fink et al.[36]). There are nonfailing
human ventricular measurements which we utilized to include
these effects[37,38].
Steady state rectification was determined by dividing current by
driving force, then normalizing. Rectification was shown to be
[K
+]o-dependent in the nonfailing human ventricle by Bailly
et al.[37]. A linear shift in V1/2 for rectification toward more
depolarized potentials with elevated [K
+]o was incorporated, as
was shown experimentally (compare to Bailly et al., their
Figure 1. Undiseased human ICaL experiments and model validation. A) Experiments: ICaL traces for currents carried by Ca
2+ (top), Ba
2+
(middle), and Sr
2+ (bottom). The voltage protocol is below the Ca
2+ traces. Ca
2+ current decay was visibly more rapid than decay for Ba
2+ or Sr
2+
currents. Simulations: ICaL in response to the same voltage protocol with CDI (CDI+VDI, top), and without CDI (VDI-only, bottom). B) Experimental data
are on the left (white circles, N=5, from 3 hearts). Simulation results are on the right (solid lines). FRC is fractional remaining current. Times after peak
current shown are from 5 to 55 ms, in 5 ms steps (indicated by arrow). Top left) Experiments showing the voltage and time dependence of FRC with
Ba
2+ as charge carrier (VDI only). Top right) Simulations of FRC, with n2gate=0 (representing VDI only; see text and panel E). Bottom left)
Experiments showing FRC with Ca
2+ as charge carrier (CDI and VDI are concurrent). FRC for CDI+VDI was significantly smaller at more hyperpolarized
potentials (Vm=220 to 0 mV, dashed box) than FRC for VDI-alone. Bottom right) Simulations of FRC with free running n gate, allowing both CDI and
VDI to occur. C) Data are from Magyar et al.[11] (black squares), Fulop et al.[12] (black diamonds), and previously unpublished (white circles, N=5,
from 3 hearts). Simulation results are solid lines. From left to right, top to bottom: steady state activation, steady state inactivation, fast time constant
for VDI, slow time constant for VDI, relative weight of the fast component for VDI, I–V curve, experiments showing recovery from inactivation, and
corresponding simulations. D) Human AP clamp waveform, used to elicit 1 mM nisoldipine sensitive current (ICaL, experiments, left) and comparison to
simulations using the same AP clamp (right). E) Schematic diagram for the n gate, representing the fraction of L-type channels undergoing CDI.
Calmodulin (CaM) is constitutively attached to the L-type channel. Ca
2+ ions bind to CaM (on-rate k1 and off-rate k-1). With Ca
2+ ions bound, the Ca
2+/
CaM/channel complex may activate CDI mode (asterisk and black color indicate CDI activation, on-rate k2 and off-rate k-2).
doi:10.1371/journal.pcbi.1002061.g001
Undiseased Human Cardiac Action Potential
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+]o-dependence
of inactivation. We introduced the time dependent xK1 gate, based
on these data. As was shown experimentally, both V1/2 and the
slope factor for inactivation depend linearly on [K
+]o. The time
constant for inactivation was based on measurements in nonfailing
human ventricular myocytes by Konarzewska et al.[38] (their
Figure 1C). Conductance was observed to be in proportion to the
square root of [K
+]o in the human ventricle[37]. When assembled,
the IK1 model demonstrated correspondence with the measured
amplitude and rectification profile, and with Bailly data for [K
+]o-
dependence. As in Jost et al.[39], IK1 was voltage dependent, but
not pacing rate dependent (Supplement Figure S4 in Text S1).
Rapid Delayed Rectifier K
+ Current (IKr)
The model for IKr was constructed using experimental data
measured in isolated undiseased human ventricular myocytes at
37uC (Figure 3A, white circles). Measurements were carried out
with/without addition of 1 mM E-4031 to the standard bath
solution in order to obtain the difference current. Tail currents
were elicited by stepping from 240 mV to various potentials for
1000 ms, and then stepping back down to 240 mV. The
deactivation time constant was determined by fitting the tail
current decay. The time constant for activation was found by
stepping from 240 mV to various potentials for various durations
preceding a step back to 240 mV. The rate with which the
envelope of tail currents developed at different voltages was
measured with an exponential fit to obtain the time constant for
activation. Since this process was well fit by a single exponential,
we made the fast and slow time constants in the model converge
on the activation limb, at depolarized potentials. The steady state
activation curve was determined from the I–V curve, after dividing
by the driving force, assuming maximal activation at the time of
peak tail current. Slow deactivation of IKr (experiments and
simulations, Figure 3B), suggests its participation in AP shortening
during steady state pacing at fast rate and at short diastolic
intervals during restitution; this hypothesis will be explored in a
later section. The fast inactivation (rectification, instantaneous in
the model) RKr gate was determined so that current profile
matched experiments using a human AP voltage clamp
(Figure 3C). Important features of the experimental AP clamp
trace that the model reproduced include 1) the early recovery
phase, where approximately half maximal current appeared by the
beginning of the AP plateau, followed by 2) quasi-linear current
increase until peak current was reached during late phase-3 of the
AP.
Since enzymes used to disaggregate myocytes can significantly
degrade IKr[40], conductance was scaled to provide correct
APD90 in control and with IKr block, measured in small tissue
preparations. Indeed, APD90 was a function of IKr conductance
(parameter sensitivity, Supplement Figure S15 in Text S1). As in
undiseased human ventricle experiments[39], IKr was voltage
dependent, but not pacing rate dependent (Supplement Figure S5
in Text S1).
Slow Delayed Rectifier K
+ Current (IKs)
Data from Vira ´g et al.[41], measured in isolated undiseased
human ventricular myocytes at 37uC, were used to construct the
modelforIKs(Figure 3D).Themodelhastwogates:xs1and xs2.The
xs1 gate is responsible for activation. Deactivation was controlled by
xs2. Activation/deactivation separation was based on the fact that
activation was much slower than deactivation. Setting tx1..tx2 at
hyperpolarized potentials, where deactivation dominated, and
tx2,,tx1 at depolarized potentials, where activation dominated,
allowed for separation of these processes as two gates. As in the case
of IKr, it is understood that IKs is damaged (reduced) by enzymatic
disaggregation of myocytes[42]. Therefore, we used IKs specific
drug block(1 mMHMR-1556)effectsonAPD90, measuredinsmall
tissue preparations, to determine the correct conductance. Ca
2+
dependence of IKs was incorporated based on measurements by
Tohse et al.[43]. The effect of this dependence was negligible under
physiological Ca
2+ concentration conditions.
Fast Na
+ Current
Fast INa was formulated using nonfailing human ventricular
data from Sakakibara et al.[44] (Figure 4A). Since Sakakibara
experiments were performed at 17uC, a temperature adjustment
was used to obtain the final model equations, representing
behavior at 37uC. The effect of temperature on steady state
gating was shown by Nagatomo et al.[45]. For activation, V1/2
shift with temperature change from 23 to 33uC was +4.3 mV. For
inactivation, the shift was +4.7 mV. We shifted V1/2 by twice these
amounts, assuming linearity (adjust to 37uC from data taken at
17uC, a change of 20uC; Nagatomo showed a change of 10uC).
Time constants were adjusted to 37uC using Q10. We set Q10=2
since Q10 was given as ‘‘about two’’ by Nagatomo.
Hanck and Sheets[46] documented a shift in V1/2 with the
passage of time after patch clamp commencement. For activation,
the shift was 20.47 mV/min. It was 20.41 mV/min for in-
activation. Sakakibara reported the time elapsed between patching
and measurement for steady state activation and inactivation as
between 10 and 20 min, ,15 min for both. Thus, we reversed the
time dependent shifts in V1/2.
CaMK effects on INa were based on available data[47]. We took
into account the measured 26.2 mV V1/2 shift in steady state
inactivation, the roughly 3-fold slowing of current decay, and the
1.46-fold slowing of recovery from inactivation.
The non-temperature adjusted model I–V curve matches
Sakakibara data at 17uC. We determined appropriate channel
conductance at 37uC based on conduction velocity, and maximum
dVm/dt. Conduction velocity in a one dimensional fiber simulation
was 45 cm/s during 1 Hz pacing, consistent with available (dog)
experiments[48]. It was 70 cm/s when stimulated from quiescence,
consistent with in vivo measurements in nonfailing human
hearts[49]. Maximum dVm/dt was 254 mV/ms in single cells at
1 Hz pacing, consistent with measurements from nonfailing human
ventricular myocytes at 37uC (234628 mV/ms)[50].
Figure 2. Undiseased human Ito,I NaCa, and IK1 experiments and model validation. A) Ito. Experimental data are white circles (N=8 from 5
hearts for inactivation time constants, N=10 from 5 hearts for recovery time constants, N=9 from 6 hearts for steady state inactivation, and N=23
from 8 hearts for the I–V curve). Simulation results are solid lines. From left to right, top to bottom: steady state activation, steady state inactivation,
fast time constant for inactivation, slow time constant for inactivation (insets show fast and slow recovery from inactivation), relative weight of the
fast component for inactivation and the I–V curve (normalized). B) INaCa. Experimental data are digitally averaged time traces (N=3 from 2 hearts,
white circles, gray is standard error of the mean). Simulation results are the solid line. Top) Voltage clamp protocol. Bottom) INaCa in response to the
clamp. C) IK1. Experimental data are previously unpublished (white circles, N=21 from 12 hearts), from Bailly et al.[37] (black squares) and
Konarzewska et al.[38](black triangles). Simulation results are solid lines (black, gray and dashed black for [K
+]o=4, 8 and 20 mM). Top left) Voltage
and [K
+]o dependence of steady state rectification. Top right) Voltage and [K
+]o dependence of steady state inactivation. Bottom left) Time constant
for inactivation. Bottom right) I–V curve, and its [K
+]o dependence.
doi:10.1371/journal.pcbi.1002061.g002
Undiseased Human Cardiac Action Potential
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+ Current
Data used in the formulation of late INa were from Maltsev
et al.[51], measured in the nonfailing human ventricle (Figure 4B),
functionally defined in experiments and simulations as the Na
+
current remaining after 200 ms from the onset of depolarization.
Steady state activation was derived from the I–V curve (current
divided by driving force, then normalized). The time constant for
activation of late INa was identical to that for fast INa. It is not
possible to measure the time to peak for late INa because of the
interfering effects of the much larger INa. However, in the model
scheme, the measurement is irrelevant for the same reason.
The hL gate is responsible for both development of and recovery
from inactivation. The time constant for development was
adjusted using Q10=2.2, as measured by Maltsev et al.[52]
(hNav1.5 channels expressed heterologously). The time constant
was voltage independent[51]. Maltsev et al.[51] reported a
maximum late INa of 20.356 pA/pF in nonfailing human
ventricular myocytes (average current between 200 and 220 ms
during step to 230 mV from 2120 mV, their Table 2, donor
heart average). We scaled the Maltsev I–V curve to the donor
value and used it to determine the model conductance.
We do not consider fast and late Na
+ currents to be separate
channels. Rather, they have long been understood to represent
different gating modes (experiments[52], and simulations by our
group[53]), separated functionally in time. In experiments, and in
simulated reproductions of experiments, late INa was functionally
defined as the INa current persisting 200 ms after onset of
depolarization. CaMK dependence was implemented (26.2 mV
V1/2 shift in steady state inactivation, and 3-fold slowing of
inactivation time constant, as measured[47]).
Figure 3. Undiseased human IKr and IKs experiments and model validation. A) IKr. Experimental data are white circles (N=10 from 7 hearts
for steady state activation, N=7 from 3 hearts for activation and from 2 hearts for deactivation time constants and weights, and N=10 from 7 hearts
for tail currents). Simulation results are lines. From left to right, top to bottom: steady state activation, time constant for activation (fast (solid) and
slow (dashed) time constants converge), fast time constant for deactivation, slow time constant for deactivation, relative weight of the fast
component for deactivation, and the I–V curve for normalized tail currents. B) Activation/deactivation profiles in response to the voltage steps shown
(240 mV holding potential to +30 mV steps of various duration, followed by a return to 240 mV, top right inset). Experiments are above. Simulations
are below. Activation is rapid, occurring within tens of milliseconds. Deactivation is slow, occurring after several seconds. C) Human AP clamp
waveform (top), used to elicit 1 mM E-4031 sensitive current (IKr, bottom); experiments are on the left, and comparison to simulations using the same
AP clamp is on the right. D) IKs. Data are from Vira ´g et al.[41] (black circles). Simulation results are solid lines. From left to right: steady state activation,
time constant for activation (much slower than deactivation at depolarized potentials), time constant for deactivation (much faster than activation at
hyperpolarized potentials), and the I–V curve, showing normalized tail currents.
doi:10.1371/journal.pcbi.1002061.g003
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+/K
+ ATPase Current (INaK)
The model for INaK was reformulated based on the work of
Smith and Crampin[54]. The Smith and Crampin model includes
more detail than standard formulations employed by other
ventricular AP models[9,10,34,35]. Importantly, the Smith and
Crampin framework includes [K
+]i dependence and inputs for
ATP and pH sensitivity. Here, we set ATP and pH values to
normal physiological levels (pH was dynamic when stated).
Dynamically changing [K
+]i is a known and meaningful pump
regulator that is a functioning part of this model. High [K
+]i
(combined with low ATP) can make the pump reverse, bringing
Na
+ in, as has been observed in isolated hearts[55].
The Smith and Crampin model (schematized in Supplement
FigureS6inTextS1)was adjustedtoreproducethe basicfindingsof
Nakao and Gadsby[56], demonstrating [Na
+]o dependence, [Na
+]i
dependence with high and low [Na
+]o,a n d[ K
+]o dependence with
high and low [Na
+]o (Supplement Figure S7 in Text S1). To
determine human ventricle appropriate conductance for INaK,w e
used [Na
+]i-frequency data presented by Pieske et al.[57] as a target
(nonfailing human left ventricular myocytes at 37uC).
The INaK formulation is based on known biophysical proper-
ties[54]; its behavior reproduces available experimental observa-
tions[56] (Supplement Figure S7 in Text S1). However, no direct
measurement of INaK has been made in the nonfailing or
undiseased human ventricle. To endow human ventricle specificity
to INaK, our strategy was indirect; reproducing the rate
dependence of intracellular Na
+ concentration, [Na
+]i, measured
in the nonfailing human ventricle was the target. This choice
Figure 4. Nonfailing human fast INa and late INa experiments and model validation. A) Fast INa. Experiments are from Sakakibara et al.[44]
(black squares) and Nagatomo et al.[45] (black triangles). Simulation results are solid lines. From left to right, top to bottom: steady state activation,
time to peak (experiment) and activation time constant (simulation), steady state inactivation, fast time constant for development of inactivation,
slow time constant for development of inactivation, time constant for recovery from inactivation, and the I–V curve (solid line simulation and data at
17uC, dashed line simulation at 37uC). In other panels, simulations and data were adjusted to 37uC. Time to peak was fit at 33uC. B) Late INa.
Experiments are from Maltsev et al.[51] (black squares). Simulation results are solid lines. Top) Steady state activation. Middle) Steady state
inactivation. Bottom) I–V curve.
doi:10.1371/journal.pcbi.1002061.g004
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physiological [Na
+]i. In the model, [Na
+]i and its relative changes
with pacing rate are controlled by INaK conductance (,0.5 mM
change per 20% change in INaK conductance, Supplement Figure
S18 in Text S1). In the absence of direct human ventricle INaK
measurements, validation of the INaK formulation employs this
relationship.
Human AP Characteristics and APD
Figure 5 shows a schematic diagram of the human ventricular
AP model. The scheme was largely unchanged from the recent
dog ventricular model by Decker et al.[19]. However, additional
targets for CaMK were included, as described above, based on
new findings. Currents were reformulated based on new
undiseased or published nonfailing human experiments. These
are colored gray in Figure 5. Currents and fluxes colored white in
the figure were based on human specific measurements of rate
dependence of intracellular Na
+ and Ca
2+ concentrations ([Na
+]i
and [Ca
2+]i, respectively), which these currents/fluxes affect.
Equations for currents and fluxes were not adopted from other
human or animal models without substantive modification; all
equations were reformulated with the exceptions of Ca
2+ buffers,
CaMK kinetics, and background currents, for which we used
Decker et al.[19] formulations and adjusted conductances. Model
equations for all major currents were completely reformulated (i.e.
fast INa, late INa,I to,I CaL,I Kr,I Ks,I K1,I NaCa, and INaK). Relevant
details precede equations in Supplement Text S1.
Microelectrode AP recordings from undiseased human ventric-
ular endocardium at 37uC were used to validate basic human
model AP characteristics. Figure 6A shows simulated APs and
experimentally measured example APs for comparison during
steady state pacing at the cycle lengths (CLs) indicated. We also
compared simulated values for resting voltage, maximum voltage,
and the maximum upstroke velocity, dVm/dt, with experiments
(Figure 6B). These comparisons were made for a single beat,
stimulated from the quiescent state.
For steady state rate dependence, we compared APD30–90
after pacing at different CLs (Figure 7A). For restitution, we
Figure 5. Schematic diagram of human ventricular myocyte model. Formulations for all currents and fluxes were based either directly (gray)
or indirectly (white) on undiseased or nonfailing human experimental data. Model includes four compartments: 1) bulk myoplasm (myo), 2) junctional
sarcoplasmic reticulum (JSR), 3) network sarcoplasmic reticulum (NSR), and 4) subspace (SS), representing the space near the T-tubules. Currents into
the myoplasm: Na
+ current (INa; representing both fast and late components), transient outward K
+ current (Ito), rapid delayed rectifier K
+ current (IKr),
slow delayed rectifier K
+ current (IKs), inward rectifier K
+ current (IK1), 80% of Na
+/Ca
2+ exchange current (INaCa,i), Na
+/K
+ pump current (INaK),
background currents (INab,I Cab, and IKb), and sarcolemmal Ca
2+ pump current (IpCa). Currents into subspace: L-type Ca
2+ current (ICaL, with Na
+ and K
+
components ICaNa,I CaK), and 20% of Na
+/Ca
2+ exchange current (INaCa,ss). Ionic fluxes: Ca
2+ through ryanodine receptor (Jrel), NSR to JSR Ca
2+
translocation (Jtr), Ca
2+ uptake into NSR via SERCA2a/PLB (Jup; PLB - phospholamban), diffusion fluxes from subspace to myoplasm (Jdiff,Na,J diff,Ca, and
Jdiff,K). Ca
2+ Buffers: calmodulin (CMDN), troponin (TRPN), calsequestrin (CSQN), anionic SR binding sites for Ca
2+ (BSR), anionic sarcolemmal binding
sites for Ca
2+ (BSL). Ca
2+/calmodulin-dependent protein kinase II (CaMK) and its targets are labeled.
doi:10.1371/journal.pcbi.1002061.g005
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PLoS Computational Biology | www.ploscompbiol.org 10 May 2011 | Volume 7 | Issue 5 | e1002061compared APD30–90 after steady state S1 pacing at
CL=1000 ms, followed by a single S2 extrasystolic stimulus
delivered at various diastolic intervals (DIs, measured relative to
APD90, Figure 7B). Model AP repolarization from 30 to 90%
quantitatively reproduced this extensive dataset (simulation results
were within experimental error bars). Generally, electrotonic
effects of tissue coupling were minor (see Discussion and
Supplement Figure S8 in Text S1).
The rate of repolarization in the model was gradual, as in
experiments (APD30–90 were well separated in time, Figure 7C).
Other models repolarized more rapidly and late compared to these
experiments (simulations were all endocardial cell types).
Koller et al.[58] measured dynamic restitution in the nonfailing
human ventricle with monophasic AP electrodes. Following the
Koller protocol (explained in Methods), the human model
matched Koller results (Figure 7D). Simulations predict a
bifurcation (alternans) at shortest DIs (,90 ms), which is also
observed in the experiments.
Steady state rate dependence and restitution of the undiseased
human ventricular APD were also measured in the presence of
channel-specific blockers (Figure 8, white squares, see Methods for
further details). In Figure 8, drugs and applied doses are provided
for each experiment. Simulated block was based on experimental
dose-response measurements (E-4031[59], HMR-1556[60], nisol-
dipine[61], BaCl2[62], ryanodine[63], and mexiletine[64], for
block of IKr,I Ks,I CaL,I K1,J rel, and late INa, respectively).
Simulations matched these experiments; that is, simulation results
were within experimental error bars.
As pacing CL was decreased from 2000 to 300 ms, currents in
the human ventricular AP model changed accordingly (Figure 9).
Due to increased refractoriness at faster rates, maximum fast INa,
late INa, and Ito were reduced. By contrast, peak ICaL increased,
Figure 7. Undiseased human endocardial AP response to pacing protocols from experiments (small tissue preparations) and model
simulations. A) Steady state APD rate dependence. B) S1S2 APD restitution (DI – diastolic interval). APD30–90 are labeled at right. Solid lines are
simulation results; white squares are experiments at 37uC (N=140 hearts in panel A, N=50 hearts in panel B). C) Repolarization rate at CL=1000 ms.
Trajectory of APD30 to APD90 is accurate in the ORd model (white squares are experimental data); less so in other models. D) Dynamic restitution
protocol (see Methods). Experiments are from Koller et al.[58], measured in nonfailing human hearts with monophasic AP electrodes (black squares).
Simulated results are the black line. At very short diastolic intervals (DI,90 ms), the model shows APD bifurcation (alternans).
doi:10.1371/journal.pcbi.1002061.g007
Figure 6. Undiseased human endocardial AP traces from experiments (small tissue preparations) and model simulations. Simulated
APs for a range of pacing frequencies (top) and corresponding examples of experimentally recorded APs at 37uC (below). Arrows indicate cycle length
(CL) changes. B) Comparison of simulation (black) and experimentally measured (gray, small tissue preparations) basic AP parameters for a single
paced beat from quiescence (37uC, N=32 from 32 hearts). Shown, from top to bottom, are the resting membrane potential (Vm rest), maximum
upstroke potential (Vm max), and maximum upstroke velocity (dVm/dt max).
doi:10.1371/journal.pcbi.1002061.g006
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IKr and IK1 were largely rate independent. Mild IKs accumula-
tion[66] caused rate dependent increase in current. INaK became
larger due to intracellular Na
+ accumulation at fast pacing rates
(details below). INaCa,i, and INaCa,ss became more inward, in order
to remove increasing Ca
2+.
Transmural Heterogeneity
Changes in mRNA and protein expression across the transmural
wall using undiseased human ventricles were measured[67,68,69].
Functional data for transmural changes in Ito were measured in
nonfailing human ventricular myocytes[70]. These results were
compiled to create a complete dataset for transmural differences
between endocardial (endo), mid-myocardial (M), and epicardial
(epi) cell types. We considered transmural differences in Nav1.5,
Cav1.2,HERG1,KvLQT1,Kir2.1,NCX1,Na/KATPase,Kv1.5,
RyR2, SERCA2, and CALM3 to be represented in the model by
late INa,I CaL,I Kr,I Ks,I K1,I NaCa,I NaK,I Kb,J rel,J up, and CMDN,
respectively. Whenever an expression ratio was not available, we
chose unity. Using this analysis, models for M and epi cells were
derived from the thoroughly validated endo model (Figure 10A–
10D; equations on page 19 in Supplement Text S1).
In Figure 10E1, our experimental measurements for endo
APD90 were scaled by M/endo and epi/endo APD90 ratios
measured by Drouin et al.[50] and compared to simulations.
Drouin experiments did not show results for CL,1000 ms. Epi
simulations seem to deviate from Drouin experiments at faster
pacing rates. However, epi simulations were consistent with
nonfailing human epi experimental measurements at fast pacing
rates (CL ,1000 ms) recorded using optical mapping by Glukhov
et al.[71] (panel E2). The rate dependence of simulated AP
morphology in the different cell types (Figure 10F) was similar to
Drouin recordings[50]. Relative shape and duration of simulated
transmural APs were also consistent with those recorded by
Glukhov et al.[71] from the heart of a 20 year old healthy human
male (Supplement Figure S9 in Text S1). The transmural
repolarization gradient direction was such that the pseudo-ECG
T-wave was upright and rate dependent[72] as expected
(Figure 10G).
Early Afterdepolarization (EAD)
Experiments from Guo et al.[73] in isolated nonfailing human
ventricular endo myocytes showed EADs when paced very slowly
(CL=4000 ms) in the presence of the IKr blocker dofetilide
Figure 8. Pacing protocols with block of various currents. Experimental data (small tissue preparations) are white squares. A) Steady state
APD90 rate dependence. From left to right, top to bottom: N=140, 5, 5, 5, 5, 4, and 4 hearts. Shown are control, IKr,I Ks,I CaL,I K1, RyR, and late INa block.
B) APD90 restitution (S1=1000 ms). From left to right: N=50, 3, and 4 hearts. Shown are control, IKr, and IKs block.
doi:10.1371/journal.pcbi.1002061.g008
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PLoS Computational Biology | www.ploscompbiol.org 12 May 2011 | Volume 7 | Issue 5 | e1002061Figure 9. Rate dependence of currents at steady state. Black arrows indicate CL decrease (rate increase). Top Row) Simulated APs, repeated in
each column for timing purposes. Lower Rows (left to right, top to bottom): INa, peak INa detailed time course, late INa,I to,I CaL,I CaL increasing peaks
with increasing pacing rate, IKr,I Ks,I K1,I NaCa,i,I NaCa,ss, and INaK. Insets show greater detail of late small Ito window current, and early IKr spiking at fast
rates.
doi:10.1371/journal.pcbi.1002061.g009
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Guo experimental results and simulation results of the same
protocol using the ORd model, and the GB and TP models (all for
endo cells at steady state). As in the experiment, the ORd model
produced an EAD when paced at slow rate (CL=4000 ms) with
block of IKr (85%). Experiments and simulations both show a
Figure 10. Transmural heterogeneity and validation of transmural cell type models. A–C) Expression ratio in the model (black bars)
compared to experimental data from undiseased human hearts (grayscale bars, labeled). D) Transmural heterogeneity of Ito; simulations are lines,
experiments are squares. Results for endo are gray; those for epi are black. E1) Rate dependence of APD90 in endo, M, and epi cell types. Epi and M
data were obtained by scaling endo data (white squares) by epi/endo and M/endo APD90 ratios from Drouin et al.[50] (black squares). Simulations are
black lines. E2) Same format as panel E1, showing epi APD90 at faster pacing rates. Data are from Glukhov et al.[71], (epi/endo scaling, black
triangles). F) Top to bottom: Rate-dependence of endo, M, and epi APs. G) Pseudo-ECG, using a simulated transmural wedge. CL changes are
indicated by arrows.
doi:10.1371/journal.pcbi.1002061.g010
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produce an EAD following the same protocol (CL=4000 ms),
even with complete block of IKr (100%).
EADs in the ORd model were caused by IKr block induced
prolongation of the time at plateau voltages, allowing ICaL
reactivation. When ICaL recovery was prevented, the EAD was
eliminated (inactivation gate clamping protocol, Figure 11B).
This mechanism is the same as shown previously in other
species[75].
Na
+ and Ca
2+ Rate Dependence
Using data from nonfailing human ventricle, we validated rate
dependent changes in concentrations of intracellular Na
+ and
Ca
2+. For [Na
+]i changes with pacing rate, we used data from
Pieske et al.[57], measured in the nonfailing human ventricle,
normalized to 0.25 Hz pacing rate (Figure 12A). Reproduction of
this curve implied that INaK magnitude was accurate (INaK
conductance controls intracellular Na
+, thus rate dependence of
relative accumulation, Supplement Figure S18 in Text S1). For
Ca
2+, we used data from Schmidt et al.[76], normalized to the
value at 0.5 Hz pacing rate. A personal correspondence with
senior author J. Gwathmey revealed that pacing in the
experiments was for about 100 beats (long enough to reach
apparent steady state). Following this protocol, we showed the
reduction in peak Ca
2+ observed at the fastest pacing rates
(Figure 12B). However, at true steady state, peak Ca
2+ increased
monotonically with pacing rate (shown in Figure 13).
Using Fura-2-AM fluorescence data measured in an undiseased
isolated human ventricular myocyte at 37uC, we determined that
the ORd model showed accurate intracellular Ca
2+ decay
(Figure 12C and 12D). Time constant fits were a single
exponential decay from time of peak Ca
2+. The decrease in decay
time constant observed with increase in pacing rate is a measure of
frequency dependent acceleration of relaxation, an important
validation of Ca
2+ cycling.
Ca
2+ Cycling and CaMK
As pacing rate increased, so did the CaMK active fraction
(CaMKactive, Figure 13A, validated previously[31,77]). CaMK was
important for controlling rate dependence of Ca
2+ cycling in the
model. In the absence of CaMK: Ca
2+ transient amplitude was
reduced, diastolic Ca
2+ was elevated, JSR Ca
2+ content and
evacuation were rate independent, and Ca
2+ reuptake (Jup) and
release (Jrel) were severely blunted (Figure 13B).
Alternans
Koller et al.[58] showed that in the nonfailing human ventricle
(in vivo monophasic AP recordings), APD alternans appeared at
CLs ,300 ms (rates .200 bpm). The amplitude of APD alternans
was ,10 ms. These findings were reproduced by the human
Figure 11. Early afterdepolarizations (EADs). A) Top left) Experiments in isolated nonfailing human endo myocytes from Guo et al.[73] showed
EADs with slow pacing (CL=4000 ms) in the presence of IKr block (0.1 mM dofetilide, ,85% IKr block[74], reproduce with permission). Top right)
Following the experimental protocol of Guo et al. (CL=4000 ms, 85% IKr block) the ORd model accurately showed a single large EAD. Bottom) GB
(left) and TP (right) models failed to generate EADs (CL=4000 ms, even with 100% IKr block). B) EAD mechanism. APs are on top. ICaL (black) and ICaL
recovery gate (gray) are below. Slow pacing alone (CL=4000 ms) did not cause an EAD (left). Slow pacing plus IKr block (85%) caused an EAD (solid
lines, right). The EAD was depolarized by ICaL reactivation during the slowly repolarizing AP plateau (solid lines, solid arrows). When ICaL recovery was
prevented, the EAD was eliminated (dashed lines and dashed arrow).
doi:10.1371/journal.pcbi.1002061.g011
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Pacing at rates faster than 230 ms in the model caused 2 to 1 block
(i.e. failed APs every other beat), because APD began to encroach
upon the pacing cycle length, leading to enhanced refractoriness of
Na
+ current due to incomplete repolarization.
Since Koller measurements were performed in intact hearts,
electrotonic coupling effects would have played a role. Therefore,
simulations in a strand of 100 coupled endo cells were conducted
to test whether alternans occurred in coupled tissue as well.
Indeed, during CL=280 ms steady state pacing, alternans
developed in the multicellular fiber (results shown in Supplement
Figure S10 in Text S1).
As in Livshitz et al.[77], beat to beat alternans in the Ca
2+
subsystem were the cause of the APD alternans in the model.
Longer APs coincided with larger Ca
2+ transients. For steady state
pacing at 250 ms pacing cycle length (shown in Figure 14A), we
found that clamping the subspace Ca
2+ concentration to either the
odd or even beat waveforms eliminated alternans, but clamping of
the voltage, myoplasmic Ca
2+,I CaL,o rI NaCa did not eliminate
alternans (odd or even beat clamp, not shown).
Cutler et al.[78] demonstrated that 30% SERCA upregulation
eliminated alternans. Similarly, in our human model, a 20%
increase in Jup magnitude eliminated alternans (shown in
Supplement Figure S11 in Text S1). CaMK suppression also
eliminated alternans in the model (Figure 14A and 14B, gray
traces). At slower pacing rates, APD was minimally affected by
CaMK suppression. However, the peak Ca
2+ concentration was
markedly reduced, especially at faster rates (Figure 14C).
Currents Participating in Steady State APD Rate
Dependence and APD Restitution
In order to describe the mechanisms underlying steady state rate
dependence and restitution of the APD in the model, it is instructive
to first systematically determine which currents participate in these
phenomena. In Figure 15, currents were plotted versus Vm during
steady state and S1S2 restitution pacing for a variety of CLs and
DIs, respectively. If I–V curves are CL or DI independent (i.e.
curves overlap), then that current did not participate in steady state
rate dependence or restitution, respectively. Conversely, if I–V
curves depended greatly on CL or DI, then that current played at
least some role in these phenomena.
As CL or DI decreased, fast INa, responsible for the maximum
AP upstroke velocity and maximum Vm, was reduced (see Figure 9,
and principles detailed in Luo and Rudy[79]). This is because
shortened time at resting potential between beats prevents
complete recovery from inactivation. Thus, at fast pacing rates,
and short DIs, maximum Vm and upstroke velocity were reduced,
explaining some of what follows.
During steady state pacing, IKs was strongly rate dependent
(Figure 15A). The I–V curves were dramatically different at
different pacing CLs. However, IKs was a relatively small
contributor to the rate dependence of APD because IKs density in
Figure 12. Rate dependence of intracellular ion concentrations. Simulation results are solid lines. A) [Na
+]i versus pacing frequency
(normalized to 0.25 Hz). Experiments are from nonfailing myocytes (Pieske et al.[57], black squares). B) Peak Ca
2+ transient (normalized to 0.5 Hz).
Experiments are from nonfailing myocytes (Schmidt et al.[76], black squares). C) Ca
2+ transients from experiments (Fura-2-AM) and simulations.
Results are normalized to illustrate the time course of decay. The arrow indicates pacing CL changes. D) Frequency dependent acceleration of
relaxation. Undiseased human experimental data are white circles. Simulations are the black line.
doi:10.1371/journal.pcbi.1002061.g012
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2+ cycling. A) Rate dependence of CaMK active fraction. B) Ca
2+ cycling under control conditions (left) and without CaMK
(right). CL changes are indicated by arrows. Top) [Ca
2+]i and diastolic values (inset). Middle) [Ca
2+]JSR. Bottom) Jup and Jrel (inset, expanded time scale).
doi:10.1371/journal.pcbi.1002061.g013
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stimulation), and changes relative to slow rate values produced
minimal additional outward current at fast rates.
Late INa,I CaL,I NaCa and INaK also showed CL dependent
changes during steady state pacing (Figure 15A). INaK became
more outward at fast rates. The changes in INaK were dramatic,
and the current density was relatively large. Thus, INaK was an
important contributor to APD shortening at fast pacing rates. Late
INa became dramatically less inward at fast rates, making it a
secondary contributor to APD shortening at fast rates. Changes in
ICaL and INaCa opposed APD shortening at fast rates; these
currents became more inward at short CLs. INaCa increased to
match the increased Ca
2+ extrusion burden. Importantly, ICaL
increased despite reduced channel availability. ICaL inactivation
gates recovered less between beats as pacing rate increased (,20%
less at CL=300 ms compared to CL=2000 ms). The same
mechanism caused reduced late INa at fast rates (availability at
CL=300 ms was ,1/3 that at CL=2000 ms). However,
Figure 14. AP and Ca
2+ alternans at fast pacing. Black lines are control. Gray lines are without CaMK. The two consecutive beats are labeled 1
and 2. A) Pacing at CL=250 ms. From left to right, top to bottom: AP, expanded time scale showing AP repolarization, Jrel (inset is expanded time
scale), [Ca
2+]i, [Ca
2+]JSR, and Jup. B) Rate dependence of APD (top) and peak [Ca
2+]i (bottom) at fast rates (alternans bifurcations disappear without
CaMK). C) Same as panel B, but at slower rates (no bifurcations).
doi:10.1371/journal.pcbi.1002061.g014
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increased driving force (reduced maximum Vm) actually caused
ICaL to become larger at fast rates.
If Na
+ is clamped to small values associated with slow pacing
([Na
+]i and [Na
+]ss=6.2 mM at CL=2000 ms), preventing its
accumulation at fast rates, INaK remains small and CL
independent (this mechanism is described later in detail), causing
plateau voltages to become relatively CL independent. Thus, with
Na
+ clamp, ICaL changes with pacing rate are different than under
control conditions. CL independent plateau voltages confer CL
independence to the driving force for plateau ICaL.N a
+ clamping
reduced Ca
2+ (via INaCa) which reduced activated CaMK and thus
ICaL facilitation. An interesting consequence is that with Na
+
clamp, ICaL changes with CL help to cause APD shortening at fast
rates, whereas in control (i.e. no Na
+ clamp), ICaL changes with CL
oppose APD shortening.
During restitution, late INa,I to,I CaL,I Ks and INaCa showed DI
dependent changes (Figure 15B). Dramatically less inward late INa
Figure 16. Major causes of steady state APD rate dependence and S1S2 APD restitution. A) APD rate dependence in control (solid black),
and with [Na
+]i and [Na
+]ss clamped to slow rate (solid gray) or fast rate (dashed black) values. When late INa (dashed gray) or both late INa and ICaL
inactivation gates were reset to their slow rate values (dash-dot-dot gray) in addition to [Na
+]i and [Na
+]ss slow rate clamp, APD lost almost all rate
dependence. Note that slow rate [Na
+]i and [Na
+]ss clamp alone left residual APD rate dependence, especially at fast rates (CL=300 to 700 ms, shaded
box). B) APD rate dependence (control, solid black) was largely unaffected by resetting inactivation gates for late INa (dashed gray), ICaL (dash-dot-dot
gray), or late INa and ICaL (solid gray) to their slow rate values (no [Na
+]i and [Na
+]ss clamping to slow rate values). C) [Na
+]i and INaK increase with
pacing rate under control conditions (left). When [Na
+]i and [Na
+]ss are clamped to slow rate values, INaK is small and rate independent (right). D) APD
restitution in control (solid black), and when inactivation gates were reset to S1 values upon S2 delivery (late INa reset – dashed gray, ICaL reset – dash-
dot-dot gray, late INa and ICaL reset – solid gray). Shown in dashed black is resetting late INa and ICaL inactivation to the DI=5 ms value. E) [Na
+]i and
[Na
+]ss clamp to S1 values (dashed gray) did not affect APD restitution (control, solid black).
doi:10.1371/journal.pcbi.1002061.g016
Figure 15. I–V curves during steady state rate dependent pacing at various CLs (panel A), and S1S2 restitution at various DIs (panel
B). Arrows indicate decreasing CL or DI. From left to right, top to bottom, results for late INa,I to,I CaL,I Kr,I Ks, zoom of plateau ICaL (dashed box section),
IK1,I NaCa, and INaK are shown.
doi:10.1371/journal.pcbi.1002061.g015
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reduced availability due to residual inactivation at the start of the
S2 beat. ICaL was reduced for the same reason. This was evident
during the plateau. CaMK facilitation did not depend on DI
because Ca
2+ accumulation (necessary for CaMK activation) is
slow, occurring only after long term pacing to steady state.
Similarly, Na
+ did not accumulate at short DIs, which kept INaK
constant. Therefore, plateau potentials and ICaL driving force
during the plateau were relatively DI independent. Just as in the
case of Na
+ clamp, these properties combined to allow reduced
availability of ICaL at short DI to dominate the behavior. However,
reduced maximum Vm increased the driving force during the time
of peak ICaL, which caused peak current to generally increase at
short DIs. At extreme DI of 5 ms, the slow AP upstroke (i.e.
reduced dVm/dt) caused mild ICaL inactivation coincident with
activation, so the peak current was reduced compared to
DI=10 ms.
Changes in other currents (Ito,I Ks and INaCa), though nonzero,
were relatively minor due to timing. DI dependent changes that
increased or reduced current during phase-1 of the AP had little
effect on final repolarization time. The exception is IKr.I Kr is large
enough that early spiking helped shorten APD at very short DIs
(detailed simulations follow).
Ionic Basis for APD Rate Dependence and Restitution
Steady state rate dependence of the APD was largely caused by
accumulation of intracellular Na
+ at fast rates. This is illustrated in
Figure 16A. When [Na
+]i and [Na
+]ss were clamped to values
from steady state pacing at CL=2000 ms, APD lost much of its
sensitivity to pacing rate and remained relatively long. Conversely,
when the clamp was to [Na
+]i and [Na
+]ss from steady state pacing
at CL=300 ms, the APD remained relatively short at all rates.
Pacing rate dependent [Na
+]i and [Na
+]ss changes are linked to the
AP via INaK, which responds to [Na
+]i levels. INaK increased with
[Na
+]i at fast rate. However it did not increase, regardless of the
pacing rate, when [Na
+]i and [Na
+]ss were kept low (Na
+ at
CL=2000 ms; Figure 16C, right). Moreover, APD remained long
at all CLs when INaK was clamped to its slow rate waveform (not
shown).
Steady state APD rate dependence was not completely
eliminated by Na
+ clamp alone. That is, clamping [Na
+]i and
[Na
+]ss to slow rate values did not cause APD curves to become
absolutely flat with respect to CL, especially at fast pacing rates
(Figure 16A, shaded box CL=300 to 700 ms, solid gray line). This
signifies that other mechanisms are involved. When in addition to
clamping [Na
+]i and [Na
+]ss to their slow rate values, we also reset
the inactivation gates for late INa, and especially for both late INa
Figure 17. IKr deactivation is important for APD restitution at very short DIs. A) APD restitution in control (solid black), and when the fast
and slow deactivation gates (xrfast and xrslow) were reset to the DI=S1=1000 ms value at the start of the S2 beat (dashed gray). Bottom) Zoom in to
more clearly show the consequence of deactivation resetting at short DIs (section outlined by dashed box above). B) Traces for the AP (top) and IKr
(bottom) during the S2 beat at different DIs (indicated by arrows). Spiking in IKr occurred early during the AP at short DI. Spiking was caused by slow
deactivation, increasing availability of IKr.
doi:10.1371/journal.pcbi.1002061.g017
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APD curve flattened further at fast rates (Figure 16A, dashed gray
and dashed-dot-dot gray lines, respectively). Importantly, resetting
these inactivation gates alone, without also clamping Na
+, had
little effect on APD rate dependence (Figure 16B).
As described previously, without Na
+ clamp, fast pacing caused
late INa reduction and ICaL increase; the former helped while the
latter opposed APD shortening. However, with Na
+ clamp, both
currents became less inward with fast pacing. Thus, resetting ICaL
inactivation gates to slow rate values had different effects with,
versus without Na
+ clamping. Na
+ clamp prolonged the APD. The
prolongation and changed ICaL behavior after Na
+ clamp
rendered late INa and ICaL gate resetting more potent effectors
of further AP prolongation; especially at fast rates where residual
inactivation between beats was substantial.
Rate dependent Na
+ changes only occurred with the steady
state pacing protocol due to slow ion accumulation after lengthy
pacing regimes. For APD restitution, clamping [Na
+]i and [Na
+]ss
to values from S1 pacing during the S2 beat did not affect APD
(Figure 16E). However, restitution was dramatically affected by
resetting inactivation gates for late INa and/or ICaL to their S1
starting values at the start of the S2 beat (Figure 16D). APD
remained long for all DIs. Conversely, when late INa and/or ICaL
inactivation gates were reset to S2 starting values for DI=5 ms,
APD remained short for all DIs. Again, resetting these inactivation
gates to their slow rate values had only minor effects on steady
state APD rate dependence (Figure 16B).
At very short DIs, IKr played an important role in APD
restitution. In Figure 17A, the fast and slow time dependent
deactivation gates (xrfast and xrslow, respectively) were reset to their
value at DI=S1=1000 ms (dashed gray line, compare to control
solid black line). Deactivation of IKr is slow (Figure 3B). For
DI=S1, deactivation was complete between beats. At short DIs, it
was incomplete at the start of the S2 beat, enhancing IKr
availability (early IKr spiking, Figure 17B, bottom) and outward
current that contributes to APD shortening. The enhanced
availability only mattered at very short DIs, because at these DIs
APD was short enough that increased outward current during
phase-1 of the AP affected final repolarization time. Changes to
currents during later AP phases 2 and 3 (during the plateau and
early repolarization, e.g. late INa and ICaL), generally have greater
impact on the APD. Early IKr spiking reduced maximum Vm,
which affected all other currents, including late INa and ICaL.
Comparison with Other Human Ventricular AP Models
Several important differences exist between the ORd model
presented here and other human models (e.g. TP[9] and GB[10]
models). Notably, model differences in the rate of repolarization
and EAD formation were examined in direct comparison with
experiments (Figures 7C, and Figure 11A, respectively). Readers
wishing to simulate the human ventricular AP have a choice of
models. To help further differentiate the models, additional
comparisons are shown in Figure 18.
Undiseased human ventricular measurements of steady state
rate dependence of APD90, 70, 50 and 30 were accurately
reproduced by the ORd model (Figure 18A, same data as in
Figure 7A). Rate dependence of APD90 is fairly accurate in the TP
model. However, rate dependence of APD70, 50 and especially
APD30 are not accurate. The GB model repolarization rate is more
accurate, but divergence from the measurements is large for
APD30. At fast pacing rates, GB model APD90 is accurate. Slow
pacing APD90 is long compared with experiments (at
CL=2000 ms, APD90 is ,40 ms longer than in experiments). In
addition, APD rate dependence does not plateau at CL=2000 ms.
In Figure 18B, the AP, major currents, and [Na
+]i and [Ca
2+]i
were compared between models. Simulations were in single endo
cells paced to steady state at CL=1000 ms. Of note, the TP and
GB models do not include late INa. The width of the ICaL peak and
the morphology were model dependent. It was ‘‘cigar shaped’’ in
the TP model. In the GB model, the ICaL peak was broad and
poorly defined. The ORd model ICaL peak was sharp, as seen in
undiseased human ventricle experiments (AP clamp, Figure 1D).
IKr was relatively small in the GB model, but shared a similar
morphology with the ORd model. The TP IKr morphology is
characterized by an early spike and a wider late spike. The IKs
density in the TP model was much larger than in the other models
(,10 fold larger). Density and morphology of INaCa was model
dependent. INaCa was smallest in the ORd model (based on
undiseased human measurements, Figure 2B). INaK was roughly
1.5 and 2 fold greater in GB and TP models, respectively,
compared with ORd. The Ca
2+ transient peak was much larger in
the TP model than in the other models, which were similar to each
other. The decay rate of [Ca
2+]i was somewhat slower in the ORd
model (accurate to undiseased human measurements; Figure 12
panels C and D). Model [Na
+]i was 7.2, 8.2, and 9.7 mM in ORd,
GB, and TP models, respectively.
Discussion
Though the available undiseased human ventricle dataset has
been missing essential elements, several human ventricle AP
models have been developed and published. The Priebe and
Beuckelmann model[35] lacks human specific data for reformu-
lation of major currents, and so was based in large part on its
guinea pig predecessor[80]. The TP model[81] and updated
version[9] is easy to use, includes many reformulated currents, and
simulates physiological restitution and alternans. However, both
the TP and GB[10] models lack sufficient ICaL data for validation,
and cannot produce EADs. The GB model includes K
+ current
reformulations using undiseased human data for validation, but
does not produce AP or Ca
2+ transient alternans. EADs and
alternans are both important mechanisms of arrhythmogenesis
and should be reproduced in simulation studies of human
arrhythmias. The Iyer et al. model[34] is based almost entirely
on data from human channels expressed in non myocytes. Though
the expressed channels are human, native myocyte ion channels in
the ventricle are composed of a variety of protein isoform
combinations, auxiliary subunits, cytoskeletal elements, and
membrane lipid composition, all of which may influence channel
behavior. Anchoring and other regulatory proteins present in
native cells also define the local environment for ICaL in
particular[82], but are not present in expression systems.
Figure 18. Comparison with other human ventricular AP models. Single endo cell simulations from ORd, TP, and GB models are solid black,
gray, and dashed black lines, respectively. Experimental results (small tissue preparations) are white squares. A) APD rate dependence. Results for
APD90, 70, 50 and 30 are shown top left, top right, bottom left, and bottom right, respectively. B) The AP, major currents, [Na
+]i, and [Ca
2+]i at steady
state for CL=1000 ms. From left to right, top to bottom: AP (with Vm rest inset at far right), INa (inset shows peaks), late INa (not present in TP or GB
models), Ito (inset shows decay rate), ICaL (arrow shows ORd peak magnitude; inset shows normalized peaks, which are wide in TP and GB), IKr (arrow
shows ORd early spike peak magnitude), IKs,I K1,I NaCa,I NaK, [Ca
2+]i, [Ca
2+]i decay rate, and [Na
+]i.
doi:10.1371/journal.pcbi.1002061.g018
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and IK1 (with [K
+]o dependence) formulations, based on
undiseased human ventricular measurements. The rate of AP
repolarization in this modified scheme is more accurate compared
with the original TP model. For these advantages, the model
sacrifices runtime speed (Markov formulation is used for IKr).
Other core issues of the TP model carry over to this modified
version (incorrect ICaL, non-physiologically large IKs, and no EAD
generation under appropriate conditions).
We believe that the new undiseased human data presented here
are essential, and substantially increase human specific model
accuracy. Due to extensive validation using these new data, our
model reproduces all of the following important physiological
behaviors: 1) CDI versus VDI inactivation of ICaL; 2) reformulat-
ed, detailed and accurate kinetics (using weighted time constants)
for Ito,I NaCa,I K1,I Kr,I Ks, fast INa, and late INa;3 )A P
repolarization rate from 30% to 90% repolarization; 4) APD at
all physiological pacing rates with/without block of major
currents, 5) APD restitution with/without block of delayed rectifier
currents; 6) transmural heterogeneity causing upright pseudo-
ECG T-wave; 7) early afterdepolarizations (EADs); 8) effects of
CaMK; and 9) AP and Ca
2+ transient alternans.
EADs and Repolarization Rate
One of the most important aspects of the model is its close
correspondence to experimental measurements of not only
APD90, but also to APD30, 50 and 70 at all physiologically
relevant pacing rates and for S1S2 restitution. This large pool of
data has previously been unavailable. Accurate repolarization rate
(i.e. time between APD30 and 90) for the restitution protocol is
crucial for simulating any phenomenon related to reentrant
arrhythmia, where head-tail interactions determine refractoriness
and vulnerability[83]. Use of new undiseased data for currents that
are active during the plateau and phase-3 of the AP (ICaL,I NaCa,
IKr and IKs) contributed to the correct repolarization rate.
The rate of repolarization and its effects on ICaL control EAD
formation in this model, as in canonical EAD explanations
[75,84]. Failure of the TP and GB models to reproduce EADs may
be due in part to their accelerated repolarization rates (Figure 7C).
It may also be caused by inaccurate formulation of ICaL
inactivation, developed in absence of the essential undiseased
human data presented here.
Steady State APD Rate Dependence
Due to the small amplitude and rapid deactivation kinetics of
IKs in the human ventricle in absence of b-adrenergic stimulation,
it does not play a major role in determining APD, APD rate
dependence, or APD restitution under basal conditions[85]
(Figure 8). This is in contrast to guinea pig ventricle, where
slower deactivation and larger amplitude IKs make it the most
important current for steady state APD rate dependence
(simulations[86] and experiments[87]). Phosphorylation by PKA
in the case of b-adrenergic stimulation greatly enhances both the
activation rate and amplitude of IKs[88]. With b-adrenergic
stimulation, IKs plays an important role in steady state APD rate
dependence[89]. Clearly, IKs is important under various circum-
stances – the AP repolarizes in human ventricle experiments even
when IKr is blocked[85], and clinical long QT syndrome type 1 is
caused by IKs loss of function[90]. Typically, isolated myocyte
patch clamp experiments underestimate IKs due to enzymatic
degradation[42]. In ORd, the role of IKs was validated using small
tissue preparations, where selective IKs block prolonged APD, but
only very modestly under basal conditions (no b-adrenergic
stimulation, ,15 milliseconds in experiments and simulations at
CL=1000 ms, Figure 8).
Block of IKr caused the most severe changes to the human AP
(rate dependence and restitution, Figure 8). However, Supple-
ment Figure S5 in Text S1, and Figure 15A show that IKr is rate
independent, as in experiments[39] and therefore was not
responsible for causing APD changes with pacing rate. Rather,
our simulations identified rate dependent changes in INaK
secondary to [Na
+]i accumulation as a primary cause of APD
rate dependence (Figure 16A, 16C). This finding is not new.
Simulations in dog ventricle[19], human atrium[91], and in the
GB human ventricle[10] models all led to this conclusion.
However, findings from the Iyer human model[34] differ, at least
in part, regarding this mechanism. In the Iyer model, [Na
+]i
affected APD rate dependence via INaCa, which is primarily
outward at fast rates. Rate dependence in the TP model[9] is less
[Na
+]i dependent because, as Grandi discussed[10], IKs is
exaggerated. Experiments by Pieske et al.[57] investigated
[Na
+]i in heart failure, versus nonfailing human ventricular
myocytes. Pieske experiments demonstrate that rate dependent
[Na
+]i accumulation is an important phenomenon in health and
disease. However, additional experiments are needed to deter-
mine whether and how [Na
+]i affects INaK and APD in human
ventricle.
In addition to INaK and INaCa (both included in the ORd
model), intracellular Na
+ is also mediated by fluxes related to H
+,
CO2, and HCO3
- homeostasis. Exchangers and cotransporters
move Na
+ ions down the electrochemical gradient in order to
offset the cost of H
+,C O 2, and HCO3
- pumping. Na
+ rate
dependent handling and consequently INaK should be affected by
these processes, which were not explicitly included in the ORd
model. In the absence of H
+,C O 2, and HCO3
- fluxes, it is possible
that the role of INaK might have been over estimated. It is
important to address this because INaK and its response to Na
+
accumulation was a major cause of APD rate dependence in the
model. Thus, we performed simulations where H
+,C O 2, and
HCO3
- effects on Na
+ were explicitly included, using Crampin
and Smith equations[92] (Supplement Figure S12 in Text S1).
Quantitative details of Na
+ handling, INaK and APD rate
dependence were affected when we included H
+,C O 2, and
HCO3
- handling processes. However, the qualitative outcomes
were not affected. INaK increase with fast pacing, secondary to Na
+
accumulation, was still the primary determinant of APD rate
dependence during steady state pacing.
Removal of the effects of Na
+ accumulation on steady state
APD rate dependence by clamping [Na
+]i and [Na
+]ss did not
completely eliminate APD rate dependence. Especially at fast rates
(Figure 16A, shaded box CL=300 to 700 ms, solid gray line),
APD was not absolutely flat with respect to CL. APD rate
dependence was largely unaffected by resetting inactivation gates
for late INa, and/or ICaL to their slow rate values at the start of
each beat (Figure 16B). Interestingly, if these gates were reset while
also clamping Na
+ to slow rate values, the APD-CL curve became
almost completely flat, even at fast rates (Figure 16A, dashed gray
and dashed-dot-dot gray lines, respectively). Thus, accumulation
of Na
+ and consequent effects on INaK is a major cause of APD
rate dependence, however, not the only cause. Other currents also
participate at fast pacing rates. Though the GB model[10]
demonstrated the Na
+/INaK/APD rate dependence mechanism,
it did not show the additional effects of late INa and ICaL. The GB
model cannot show these multi-factorial causes of APD rate
dependence because it does not include late Na
+ current
(Figure 18), and because ICaL kinetics are inaccurate due to lack
of experimental data.
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+]i is
associated with an equal reduction in [K
+]i and a volume
converted [K
+]o increase in tissue clefts and interstitial spaces[93].
This can affect behavior by increasing IK1 (its [K
+]o sensitivity is
included in this model), which depolarizes resting voltage and
reduces excitability. However, our simulations represent experi-
ments in an isolated myocyte in a large bath, where [K
+]o is
constant. Even in vivo,[ K
+]o is tightly controlled via regulation by
the lymphatic system and kidneys.
APD Restitution
We showed that in contrast to steady state rate dependence,
[Na
+]i had no effect on APD restitution. Rather, restitution was
primarily caused by the time course of recovery from inactivation
of late INa and ICaL; processes which had little effect on steady
state-rate dependence of APD (absent Na
+ clamp). At very short
DIs, slow deactivation of IKr caused increased availability and
spiking, which helped shorten the APD. APD rate dependence was
caused primarily by concentration changes, while APD restitution
was caused by gating kinetics. Previous studies have not made this
important distinction between steady state rate dependence and
restitution mechanisms in human. The role of ICaL and its
inactivation kinetics in APD restitution reiterates the primacy of
ICaL in determining basic physiological behaviors, highlighting the
importance of the new ICaL experimental data, presented here, to
model development and validation.
A role for late INa in restitution could not have been
hypothesized using TP or GB models, which have no late INa.
The density of late INa was constrained in the ORd model by
experiments from nonfailing human ventricular myocyte mea-
surements by Maltsev et al.[51], where the late current was
measured 200 ms after the start of the voltage clamp step
(,0.35 mA/mF I–V curve maximum). The maximum late INa
during the free running AP model was much smaller (,0.15 mA/
mF, about half the I–V curve maximum) even at slow pacing rates,
where late INa was largest. Late current is difficult to measure
directly, and it is possible that the current density was
overestimated due to selection bias. That is, late INa is small,
and not all cells produced measureable late current (2 of 3
myocytes[51]). However, we consider the model density of late INa
to be accurate based on model reproduction of experiments which
consistently showed substantial APD90 shortening following
application of 10 mM mexiletine in undiseased human myocardi-
um (90% late INa block in simulations, Figure 8A).
Ca
2+ Cycling, CaMK and Alternans
Previously published human ventricle AP models have not
incorporated the CaMK signaling pathway. Our human simula-
tions show, as in dog simulations[31,77], that CaMK plays an
important role in determining frequency dependence of Ca
2+
cycling (Figure 13). The model also shows that the integrated
electrophysiological consequence of CaMK effects on target
channels is minimal. That is, CaMK suppression had only minor
effects on APD rate dependence and AP morphology. At very fast
pacing (CLs ,300 ms), the Ca
2+ cycling consequences of CaMK
phosphorylation were central to alternans formation. Suppression
of CaMK eliminated alternans. CaMK related findings are in
agreement with simulations using other models developed by our
group[77], models from other groups[94], and experiments[95].
However, experiments showing the effects of pharmacological
suppression of CaMK on rate dependent behaviors (e.g. by
Wehrens et al.[96] with KN-93 in rabbit) should be performed in
human ventricular myocytes to validate model predictions.
Transmural Heterogeneity
The method used for implementation of the transmural cell
types (M and epi cell), based on the thoroughly validated endo cell
framework, was simplistic. That is, we considered that channel
conductance was proportional to transmural gradients in mRNA
or protein expression for alpha subunits of ion channels. Only in
the case of Ito were functional current measurement data
available[70]. Staying within error bars for mRNA or protein
data[67,68,69], channel conductances were modulated so that the
simulated transmural AP differences were consistent with
experiments[50,71].
The effect of transmural heterogeneity of accessory b-subunits
was not considered in the transmural cell type definitions.
However, in the case of IKs, the KCNE1 b-subunit is transmurally
heterogeneous. KCNE1 protein was about two times greater in M-
cells compared to epi cells[69]. The presence of KCNE1 carries
two important functional consequences 1) ,5 fold slower
activation and 2) ,5 fold larger conductance[97]. Therefore,
theoretically, twice as much KCNE1 in M-cells may increase the
variable stoichiometry ratio of KCNE1 to alpha subunit
KCNQ1[98], slowing activation and increasing conductance.
We conducted simulations to evaluate the influence of KCNE1
heterogeneity on IKs and the AP (Supplement Figure S13 and
related description in Text S1). Due to the small amplitude of
human IKs in the absence of b-adrenergic stimulation, implemen-
tation of KCNE1 heterogeneity did not appreciably affect the AP
(Supplement Figures S13 and S19 in Text S1, where transmural
APDs are shown to be relatively insensitive to changes in IKs
conductance). Interestingly, the simulated effects of KCNE1 on
activation rate and conductance offset one another. That is,
slowed activation and larger conductance in M-cells yielded IKs
current that was remarkably close to the control case. Similar
results were found for epi cell simulations: the effects of faster
activation and reduced conductance were offsetting such that their
combined effect was minimal.
APD Accommodation
Steady state rate dependence of APD and APD restitution were
the focus of the simulations and experiments in this study.
However, the time course of APD response to abrupt changes in
pacing rate has been shown in human by Franz et al.[99], and
simulated in the TP model by Pueyo et al.[100] as a marker for
arrhythmia risk. Simulations of APD accommodation in our
model compare favorably to Franz experiments (same pacing
protocols used in experiments were used in the simulations,
Supplement Figure S14 in Text S1). Single exponential curves
were fit to the time dependence of APD changes. For abrupt CL
reduction from 750 to 480 ms, the time constant was 250 and 284
seconds in experiments and simulations, respectively. Time
constants were 300 and 299 seconds in experiments and
simulations, respectively, when CL was abruptly returned to
750 ms. When the CL reduction was more severe, from CL=750
to 410 ms, the time constants were 252 and 165 seconds, in
experiments and simulations, respectively. For return to
CL=750 ms, the time constants were 350 and 289 seconds,
respectively. Pueyo used time to 90% accommodation to compare
model with experiments demonstrating similar accuracy. Both
simulation studies also show initial overshoot, or ‘‘notching’’, as
observed and described by Franz.
Parameter Sensitivity
As in Romero et al.[101], we performed a sensitivity analysis to
determine factors participating in important model outputs,
including 1) steady state APD90 rate dependence (Supplement
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Figure S16 in Text S1), 3) rate dependence of maximum (systolic)
[Ca
2+]i (Supplement Figure S17 in Text S1), 4) rate dependence of
[Na
+]i (Supplement Figure S18 in Text S1), and 5) transmural cell
type APD90 at steady state (Supplement Figure S19 in Text S1).
The findings from our analysis were similar to those shown by
Romero et al. using the TP human AP model[101]. That is, in
ORd and TP models, IKr and ICaL affect APD90 while ICaL,I NaCa,
and INaK affect peak [Ca
2+]i. One important difference is the role
for IKs. A much larger role was played by IKs in the TP model
(,10 fold larger density than in other human models, Figure 18B).
In the TP model, IKs is responsible for steady state rate
dependence of the APD (shown by Grandi et al.[10]).
IKr conductance changes affect APD90 substantially in our
model. This was expected, since IKr is the largest outward current
(also in experiments, Figure 8, and in Romero’s analysis using the
TP model). Though IKr affects APD, it is not responsible for its
rate dependence. Conductance changes in INaK did not substan-
tially affect APD90 because INaK is a relatively small current. Yet,
rate dependent changes in INaK (secondary to Na
+ accumulation at
fast rate) were the primary determinant of APD rate dependence.
[Na
+]i at different pacing rates, and thus its relative changes with
rate, was by far most sensitive to INaK conductance (Supplement
Figure S18 in Text S1). This supports our strategy for setting INaK
conductance to reproduce rate dependence of [Na
+]i in nonfailing
human myocytes[57].
Computational Tractability and Model Stability
To keep the ORd model computationally efficient and
parameters well constrained, the Hodgkin-Huxley formalism was
used in formulating current equations. This choice was made as a
design principal with the thought that interested users can
modularly replace any current or flux with more detailed Markov
formulations of mutation or drug effects as desired (e.g.[53,66]).
Similarly, intracellular Ca
2+ handling can be modified (e.g. more
spatial detail, Markov ryanodine receptor implementation), or
various signaling pathways and related effects on ion channels can
be added (e.g.[31,89,102]). The basic ORd model has 41 state
variables. In the absence of CaMK and its effects on target
currents and fluxes, the number of state variables is 31.
Exclusion of Markov models increases parameter constraint. It
also prevents the system of differential-algebraic equations from
being overly stiff. This promotes model stability and computa-
tional tractability. Using the rapid integration technique described
in Supplement Text S1 (Computational Methodology section), the
model arrives at true and accurate steady state in under one
minute of runtime (,1000 beats are needed, depending on the
CL, Visual C++ running on a desktop PC; more details in
Supplement Text S1). ORd equations are all smoothly varying
functions, free of singularities and ‘‘if’’ conditionals. Thus, the
model can readily be implemented in any of a variety of
automated numerical integrators, such as Matlab (The Math-
Works Inc.), CellML (http://www.cellml.org/), CHASTE[103],
or CARP (CardioSolv LLC.).
Limitations
Direct measurement of INaK in the undiseased or nonfailing
human ventricular myocyte is lacking. Therefore, INaK was
validated by reproduction of important biophysical properties
(Supplement Figure S7 in Text S1), and by reproduction of [Na
+]i
rate dependence measured in nonfailing human ventricular
myocytes (Pieske et al.[57], Figure 12A). However, independent
and direct experimental measurement of INaK in undiseased or
nonfailing human ventricular myocytes would provide additional
support for the mechanistic conclusion that INaK changes
secondary to Na
+ accumulation at fast pacing rates is a major
determinant of steady state APD rate dependence. This
conclusion is consistent with several other modeling studies
which proposed the same mechanism (dog ventricle[19], human
atrium[91], and human ventricle[10]). The relationship between
[Na
+]i,I NaK and steady state APD rate dependence was robust. It
was not disrupted by including the effects of Na
+/H
+ and Na
+/
HCO3
- exchange fluxes on Na
+ handling (Crampin and Smith
equations[92], Supplement Figure S12 in Text S1). Na
+
accumulation and INaK response were not the only cause of
APD rate dependence in the ORd model. At fast pacing rates
(CL=300 to 700 ms), late INa and ICaL were also involved
(Figure 16A, and related discussion).
Measurements of undiseased human endo APs were performed
in small tissue preparations (1–3 gram pieces). This was to avoid
possible enzymatic degradation of K
+ channel proteins[40,42],
affecting currents and the AP. However, electrical loading in tissue
subtly affects behavior[19]. We performed simulations using a
multicellular fiber model to include loading effects, which had only
minor consequences (Figure S8).
APD was ,275 ms in our human endo preparations at
CL=1000 ms, well matched by the model (273 ms). In vivo
noninvasive electrocardiographic imaging of the activation-
recovery interval, an indicator of the cellular epi APD, was
,260 ms in healthy adults[104]. Human monophasic AP
measurements are also in this range[58]. Measurements from
Drouin et al. showed longer APDs (,350 ms in endo cells on the
cut transmural face at CL=1000 ms). Having validated the endo
model based on more than 100 of our own endo AP
measurements, we thought it reasonable to use Drouin transmural
APD ratios, rather than the uniformly longer APDs themselves, for
validation of the transmural cell type models.
The presence of M cell APs in the nonfailing human heart was
observed by Drouin et al.[50], and more recently by Glukhov
et al.[71]. However, there is controversy regarding the M cell
definition and its role in human. Our M cell model was based on
data where the M cell was defined by its transmural location. The
resulting simulated M cell AP corresponded with the ‘‘max cell’’
observed by Glukhov.
Recently, Sarkar and Sobie developed a method for quantitative
analysis of parameter constraint and relationships between
parameters and target outputs in AP models[105]. We did not
apply this analysis during model development. However, the
extensive validation of channel kinetics and the emergent response
of the AP to a variety of dynamic pacing protocols, used in
development and validation of the model, ensures sufficient
parameter constraint. The parameter sensitivity tests we per-
formed were instructive, though relatively limited (conductance
changes only). Application of Sarkar and Sobie’s analysis to our
model is beyond the scope of this paper, but should provide
worthwhile insights regarding inter-relatedness of processes in the
human ventricle, in addition to formally testing parameter
constraint.
Materials and Methods
Characteristics of Human Tissue
During the last 15 years, undiseased hearts were donated for
research in compliance with the Declaration of Helsinki and were
approved by the Scientific and Research Ethical Committee of the
Medical Scientific Board of the Hungarian Ministry of Health
(ETT-TUKEB), under ethical approval No 4991-0/2010-
1018EKU (339/PI/010). Data from 140 hearts were used in this
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donor age was 41 years old with standard deviation of 12 years.
Tissue Preparation
Tissue transport and ventricular endo preparations were
performed as previously described[85]. Tissue was carefully
pinned and placed in a modified Tyrodes superfusate (in mM:
NaCl 115, KCl 4, CaCl2 1.8, MgCl2 1, NaHCO3 20, and glucose
11, pH 7.35, 37uC), and point stimulation was via bipolar
platinum electrodes. Drug solutions were made fresh on the day
of use. Drugs included in this study were, in mM: E-4031 1, HMR-
1556 1, nisoldipine 1, BaCl2 100, ryanodine 5, mexiletine 10.
Simulated application of these drugs was 70% IKr[59], and 90%
IKs[60], ICaL[61], IK1[62], RyR[63], and late INa[64] block,
respectively.
Myocyte Isolation
Tissue transport and myocyte isolation for the undiseased donor
hearts were as previously described[85]. Myocyte isolation
commenced immediately upon arrival in the laboratory, using
the perfusion disaggregation procedure, previously described[85].
Electrophysiology
Data were obtained using conventional whole cell patch-clamp
techniques. Micropipette fabrication and data acquisition were as
described previously for undiseased donor heart[85]. Axopatch
200 amplifiers, Digidata 1200 converters, and pClamp software
were used (Axon Instruments/Molecular Devices). Experiments
were performed at 37uC.
The standard bath solution contained, in mM: NaCl 144,
NaH2PO4 0.33, KCl 4.0, CaCl2 1.8, MgCl2 0.53, Glucose 5.5,
and HEPES 5.0 at pH of 7.4, and pipette solutions contained K-
aspartate 100, KCl 25, K2ATP 5, MgCl2 1, EGTA 10 and
HEPES 5. The pH was adjusted to 7.2 by KOH (+15220 mM
K
+).
For L-type Ca
2+ current measurement, the bath solution
contained in mM: tetraethylammonium chloride (TEA-Cl) 157,
MgCl2 0.5, HEPES 10, and 1 mM CaCl2, or BaCl2, or SrCl2
(pH 7.4 with CsOH). The pipette solution contained (in mM)
CsCl 125, TEA-Cl 20, MgATP 5, creatine phosphate 3.6, EGTA
10, and HEPES 10 (pH 7.2 with CsOH).
For Na
+/Ca
2+ exchange current measurement, the bath
solution contained, (in mM): NaCl 135, CsCl 10, CaCl2 1, MgCl2
1, BaCl2 0.2, NaH2PO4 0.33, TEACl 10, HEPES 10, glucose 10
and (in mM) ouabain 20, nisoldipine 1, lidocaine 50, pH 7.4. The
pipette solution contained (in mM): CsOH 140, aspartic acid 75,
TEACl 20, MgATP 5, HEPES 10, NaCl 20, EGTA 20, CaCl2 10
(pH 7.2 with CsOH).
Ca
2+ Transient Florescence
Isolated myocytes from the undiseased donor hearts were used
to measure the Ca
2+ transient during point stimulation via bipolar
platinum electrodes, indicated by Fura-2-AM, as was described
previously[106]. Bath temperature was 37uC.
Pacing Protocols
For both experiments and simulations, we determined APD at
30, 50, 70 and 90% of complete repolarization (APD30–90, in
m s ) .T h es t a r to ft h eA Pw a st h et i m eo fm a x i m u md V m/dt. The
time of APDX occurred once membrane voltage was X% of the
resting value. Resting voltage was measured immediately prior
to each paced beat. For APD rate dependence, pacing was to
steady state. For APD restitution (S1S2, or static restitution), S1
pacing was at cycle length (CL)=1000 ms. The S2 beat was
delivered at variable diastolic intervals (DIs), measured relative
to APD90.
The dynamic restitution protocol was simulated as in experi-
ments by Koller et al.[58]. Pacing was at a variety of rates (30
seconds at CLs from 230 to 1000 ms, no S2 beats). APD95 was
plotted against DI (where DI=CL – APD95). Unlike static S1S2
restitution, the dynamic restitution protocol allows for more than
one APD to be associated with a given DI. This is significant
because bifurcation in the dynamic restitution curve is believed to
be arrhythmogenic[107].
Population Based CaMK effects
For all channels affected by CaMK, we created separate
models for the fully CaMK phosphorylated channels, and the
totally non phosphorylated channels. Then, based on the degree
of CaMK activation (CaMKactive), we determined the propor-
tion of channels affected by CaMK. To calculate the CaMK
affected current (or flux), we added the weighted sum of fully
affected and totally unaffected channels, using the proportion-
ality. The model employed for CaMK activity was validated
previously[31,77].
Relative Weights in a Two Time Constant Scheme
When measurements called for a gating process to be
represented by both a fast and a slow process, we included
separate fast and slow gates. However, we did not simply multiply
fast and slow gates to modulate conductance as others have done
previously. To do so allows the fast process alone to completely
control deactivation/inactivation, and the slow process alone to
completely control activation/recovery. Rather, since measure-
ments of bi-exponential behaviors provide the relative weight of
fast/slow processes, we modeled the measurements accordingly,
and used the weighted sum of fast and slow processes.
Transmural Wedge Simulation
We computed the pseudo-ECG using a 1-dimensional model of
the transmural wedge preparation[108,109]. In brief, the spatially
weighted sum of the voltage gradient was determined at a point
2 cm from the epi end of a heterogeneous multicellular fiber, along
the fiber axis. Cells 1–60 were endo, 61–105 were M, and 106–
165 were epi. The stimulus was delivered to cell 1. Cells 15 from
both ends of the fiber were excluded from the gradient
measurement due to confounding edge effects. Pacing was for
100 beats using steady state initial conditions from paced single
cells.
Equations, Computers, and Software
All model equations, hardware and software used, and rapid
integration methods are provided in Supplement Text S1. Model
code can be downloaded from the research section of our website:
http://rudylab.wustl.edu.
Supporting Information
Text S1 Supplementary materials.
(PDF)
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